These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4982303)

  • 1. Plasma salicylate concentrations following chronic administration of aspirin as conventional and sustained-release tablets.
    Wiseman EH
    Curr Ther Res Clin Exp; 1969 Nov; 11(11):681-9. PubMed ID: 4982303
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative bioavailability of sustained-release and uncoated aspirin tablets.
    Karahalios WJ; Sawyer WT; Rittase RA; Maynard SA
    Am J Hosp Pharm; 1981 Nov; 38(11):1754-6. PubMed ID: 7304632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma salicylate levels in rheumatoid arthritis produced by four different salicylate preparations.
    Armstrong BK; Ukich AW; Goatcher PM
    Med J Aust; 1970 Jul; 2(4):181-3. PubMed ID: 4917130
    [No Abstract]   [Full Text] [Related]  

  • 4. Steady-state salicylate plasma and urinary metabolite concentrations from plain, buffered, or enteric-coated aspirin.
    Allen JH; Thakker KM; Small RE; Wood JH; Willis HE
    Clin Pharm; 1983; 2(1):64-6. PubMed ID: 6883933
    [No Abstract]   [Full Text] [Related]  

  • 5. [Analgesics; the use of aspirin in dogs; effects of tablet type and food intake on plasma salicylate level].
    Nap RC; Breen DJ; Lam TJ; Peters IO; Willemsen A; De Bruyne JJ
    Tijdschr Diergeneeskd; 1993 Jul; 118(13):439-42. PubMed ID: 8346511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enteric aspirin tablets and the salicylate concentration in the plasma in the morning].
    Laine V; Strandman D; Tikkanen R
    Lakartidningen; 1968 Sep; 65(39):3832-7 passim. PubMed ID: 5741894
    [No Abstract]   [Full Text] [Related]  

  • 7. Sustained release aspirin.
    Pomare EW; Treadwell BL
    N Z Med J; 1971 Mar; 73(466):139-43. PubMed ID: 4930820
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction of omeprazole with enteric-coated salicylate tablets.
    Nefesoglu FZ; Ayanoglu-Dülger G; Ulusoy NB; Imeryüz N
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):549-53. PubMed ID: 9799060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum salicylate concentrations after aspirin administration at 6- or 12-hour intervals.
    Butler CD; Straughn AB
    Clin Pharm; 1982; 1(5):458-60. PubMed ID: 7184679
    [No Abstract]   [Full Text] [Related]  

  • 10. Enteric-coated pelletized aspirin. Gastrointestinal blood loss and bioavailability.
    Portek I; Graham G; Fleming A
    Med J Aust; 1981 Jul; 2(1):39-40. PubMed ID: 6974303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of different aspirin formulations on platelet aggregation times and on plasma salicylate concentrations.
    Schwertner HA; McGlasson D; Christopher M; Bush AC
    Thromb Res; 2006; 118(4):529-34. PubMed ID: 16298420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood salicylates in healthy volunteers after ingestion of aspirin in conventional or buffered tablets].
    Carlini EA; Benedito MA; Zwicker AP; Calil HM; Assolant KR; Maluf E; Giraldi SM
    AMB Rev Assoc Med Bras; 1984; 30(1-2):14-6. PubMed ID: 6377403
    [No Abstract]   [Full Text] [Related]  

  • 13. Some observations on blood level data following oral administration of aspirin as tablets and capsules.
    Garnham J; Hicks DC; Raymond K; Shotton E; Turner P
    Br J Pharmacol; 1973 Jun; 48(2):336P. PubMed ID: 4582150
    [No Abstract]   [Full Text] [Related]  

  • 14. Absorption of salicylate powders versus tablets following overdose: a poison center observational study.
    Rose SR; Cumpston KL; Kim J; Difranco D; Wills BK
    Clin Toxicol (Phila); 2016 Nov; 54(9):857-861. PubMed ID: 27383649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and preliminary evaluation of sustained-release acetylsalicylic acid tablets.
    Jovanović M; Jokić D; Durić Z; Tasić L; Jovicić G
    Pharmazie; 1990 Nov; 45(11):869. PubMed ID: 2100344
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma salicylate levels after soluble and effervescent aspirin.
    Orton D; Treharne Jones R; Kaspi T; Richardson R
    Br J Clin Pharmacol; 1979 Apr; 7(4):410-2. PubMed ID: 444362
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma salicylate levels in rheumatoid arthritis: a comparison between micro-encapsulated and conventional aspirin.
    Hanson A; Lindroth Y; Sjöblom KG; Wollheim FA
    Scand J Rheumatol; 1979; 8(2):106-8. PubMed ID: 451489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a sustained-release aspirin tablet.
    Wiseman EH; Federici NJ
    J Pharm Sci; 1968 Sep; 57(9):1535-9. PubMed ID: 5674390
    [No Abstract]   [Full Text] [Related]  

  • 19. Deafness due to plain and long-acting aspirin tablets.
    Miller RR
    J Clin Pharmacol; 1978 Oct; 18(10):468-71. PubMed ID: 711928
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of pharmacokinetic and pharmacodynamic profiles of aspirin following oral gavage and diet dosing in rats.
    Kapetanovic IM; Bauer KS; Tessier DM; Lindeblad MO; Zakharov AD; Lubet R; Lyubimov A
    Chem Biol Interact; 2009 May; 179(2-3):233-9. PubMed ID: 18992230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.